References

Agundez J.A. (2004) Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 5:211–224.

Agundez J.A. (2008) Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab 9:520–531.

Ames B.N. (1979) Identifying environmental chemicals causing mutations and cancer. Science 204:587–593.

Ames B.N., Garry B., Herzenberg L.A. (1960) The genetic control of the enzymes of histidine biosynthesis in Salmonella typhimurium. J Gen Microbiol 22:369–378.

Ames B.N., Hartman P.E., Jacob F. (1963) Chromosomal alterations affecting the regulation of histidine biosynthetic enzymes in Salmonella. J Mol Biol 7:23–42.

Ames B.N., Lee F.D., Durston W.E. (1973) An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc Natl Acad Sci U S A 70:782–786.

Atherton M.J., Mason N.J. (2022) Bite-size introduction to canine hematologic malignancies. Blood Adv 6:4073–4084.

Bailey W.S. (1963) Parasites and cancer: Sarcoma in dogs associated with Spirocerca Lupi. Ann N Y Acad Sci 108:890–923.

Barrett J.C., Lamb P.W., Wiseman R.W. (1989) Multiple mechanisms for the carcinogenic effects of asbestos and other mineral fibers. Environ Health Perspect 81:81–89.

Beatty J. (2014) Viral causes of feline lymphoma: Retroviruses and beyond. Vet J 201:174–180.

Bilgic O., Duda L., Sanchez M.D. et al. (2015) Feline oral squamous cell carcinoma: Clinical manifestations and literature review. J Vet Dent 32:30–40.

Bonnet D., Dick J.E. (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730–737.

Borow M., Conston A., Livornese L. et al. (1973) Mesothelioma following exposure to asbestos: A review of 72 cases. Chest 64:641–646.

Boulaire J., Fotedar A., Fotedar R. (2000) The functions of the cdk-cyclin kinase inhibitor p21WAF1.

Boyland E. (1985) Tumour initiators, promoters, and complete carcinogens. Br J Ind Med 42:716–718.

Bozina N., Bradamante V., Lovric M. (2009) Genetic polymorphism of metabolic enzymes P450 (Cyp) as a susceptibility factor for drug response, toxicity, and cancer risk. Arhiv Za Higijenu Rada I Toksikologiju-Archives of Industrial Hygiene and Toxicology 60:217–242.

Brown J.R., Thornton J.L. (1957) Percivall Pott (1714–1788) and chimney sweepers’ cancer of the scrotum. Br J Ind Med 14:68–70.

Burningham Z., Hashibe M., Spector L. et al. (2012) The epidemiology of sarcoma. Clin Sarcoma Res 2:14.

Carnero A., Hannon G.J. (1998) The INK4 family of CDK inhibitors. Curr Top Microbiol Immunol 227:43–55.

Chambers R.W. (1985) Chemical carcinogenesis: A biochemical overview. Clin Biochem 18:158–168.

Cobrinik D., Dowdy S.F., Hinds P.W. et al. (1992) The retinoblastoma protein and the regulation of cell cycling. Trends Biochem Sci 17:312–315.

Cooke M.S., Evans M.D., Dizdaroglu M. et al. (2003) Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J 17:1195–1214.

Cooper J., Giancotti F.G. (2019) Integrin signaling in cancer: Mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell 35:347–367.

Deininger P. (1999) Genetic instability in cancer: Caretaker and gatekeeper genes. Ochsner J 1:206–209.

Demoor-Goldschmidt C., de Vathaire F. (2019) Review of risk factors of secondary cancers among cancer survivors. Br J Radiol 92:20180390.

Dobson J.M., Samuel S., Milstein H. et al. (2002) Canine neoplasia in the UK: Estimates of incidence rates from a population of insured dogs. J Small Anim Pract 43:240–246.

Duncan A.W., Marr H.S., Birkenheuer A.J. et al. (2008) Bartonella DNA in the blood and lymph nodes of Golden Retrievers with lymphoma and in healthy controls. J Vet Intern Med 22:89–95.

Dvir E., Clift S.J., Williams M.C. (2010) Proposed histological progression of the Spirocerca lupi-induced oesophageal lesion in dogs.

Dyson N., Howley P.M., Munger K. et al. (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934–937.

Efeyan A. (2007) Serrano M: p53: Guardian of the genome and policeman of the oncogenes. Cell Cycle 6:1006–1010.

Elmore S. (2007) Apoptosis: A review of programmed cell death. Toxicol Pathol 35:495–516.

Epstein J.H. (1970) Ultraviolet carcinogenesis. Photophysiology 5:235–273.

Flavahan W.A., Gaskell E., Bernstein B.E. (2017) Epigenetic plasticity and the hallmarks of cancer. Science 357.

Fleming J.M., Creevy K.E., Promislow D.E. (2011) Mortality in north American dogs from 1984 to 2004: An investigation into age-, size-, and breed-related causes of death. J Vet Intern Med 25:187–198.

Foulds L. (1954) The experimental study of tumor progression: A review. Cancer Res 14:327–339.

Foulds L. (1965) Multiple etiologic factors in neoplastic development. Cancer Res 25:1339–1347.

Frost G. (2013) The latency period of mesothelioma among a cohort of British asbestos workers (1978–2005). Br J Cancer 109:1965–1973.

Fujinaga K., Green M. (1971) Mechanism of carcinogenesis by RNA tumour viruses: The RNA-and DNA-dependent DNA polymerase activities of feline sarcoma virus. J Gen Virol 12:85–93.

Galluzzi L., Vitale I., Aaronson S.A. et al. (2018) Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 25:486–541.

Gartel A.L., Serfas M.S. (1996) Tyner AL: p21–Negative regulator of the cell cycle. Proc Soc Exp Biol Med 213:138–149.

Golias C.H., Charalabopoulos A., Charalabopoulos K. (2004) Cell proliferation and cell cycle control: A mini review. Int J Clin Pract 58:1134–1141.

Goode E.L., Ulrich C.M., Potter J.D. (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11:1513–1530.

Grana X., Reddy E.P. (1995) Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).

Granstein R.D., Sober A.J. (1982) Current concepts in ultraviolet carcinogenesis. Proc Soc Exp Biol Med 170:115–125.

Gray D.A. (1991) Insertional mutagenesis: Neoplasia arising from retroviral integration. Cancer Invest 9:295–304.

Greaves M., Maley C.C. (2012) Clonal evolution in cancer. Nature 481:306–313.

Grivennikov S.I., Karin M. (2010) Inflammation and oncogenesis: A vicious connection. Curr Opin Genet Dev 20:65–71.

Hamel P.A., Gallie B.L., Phillips R.A. (1992) The retinoblastoma protein and cell cycle regulation. Trends Genet 8:180–185.

Hamilton S.R., Vogelstein B. (1988) Point mutations in human neoplasia. J Pathol 154:205–206.

Hanahan D., Weinberg R.A. (2000) The hallmarks of cancer. Cell 100:57–70.

Hanahan D., Weinberg R.A. (2011) Hallmarks of cancer: The next generation. Cell 144:646–674.

Harper J.W. (1997) Cyclin dependent kinase inhibitors. Cancer Surv 29:91–107.

Haupt S., Berger M., Goldberg Z. et al. (2003) Apoptosis – The p53 network. J Cell Sci 116:4077–4085.

Hemminki K., Forsti A., Mustonen R. et al. (1986) DNA adducts in experimental cancer research. J Cancer Res Clin Oncol 112:181–188.

Hengst L., Reed S.I. (1998) Inhibitors of the Cip/Kip family. Curr Top Microbiol Immunol 227:25–41.

Helleday T. (2011) The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings. Mol Oncol 5:387–393.

Hoeijmakers J.H. (2001a) Genome maintenance mechanisms for preventing cancer. Nature 411:366–374.

Hoeijmakers J.H. (2001b) DNA repair mechanisms. Maturitas 38:17–22; discussion 22–23.

Hoover E.A., Mullins J.I. (1991) Feline leukemia virus infection and diseases. J Am Vet Med Assoc 199:1287–1297.

Ignatova T.N., Kukekov V.G., Laywell E.D. et al. (2002) Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39:193–206.

Iqbal N., Iqbal N. (2014) Imatinib: A breakthrough of targeted therapy in cancer.

Jarrett W.F. (1975) Cat leukemia and its viruses. Adv Vet Sci Comp Med 19:165–193.

Jeong J., Kim D., Choi J. (2022) Application of ToxCast/Tox21 data for toxicity mechanism-based evaluation and prioritization of environmental chemicals: Perspective and limitations. Toxicol In Vitro 84:105451.

Ju F., Atyah M.M., Horstmann N. et al. (2022) Characteristics of the cancer stem cell niche and therapeutic strategies. Stem Cell Res Ther 13:233.

Karihtala P., Soini Y. (2007) Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS 115:81–103.

Karran P. (2000) DNA double strand break repair in mammalian cells. Curr Opin Genet Dev 10:144–150.

King M.C., Marks J.H., Mandell J.B. et al. (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643–646.

Kinzler K.W., Vogelstein B. (1998) Landscaping the cancer terrain. Science 280:1036–1037.

Knapp D.W., Dhawan D., Ramos-Vara J.A. et al. (2019) Naturally-occurring invasive urothelial carcinoma in dogs, a unique model to drive advances in managing muscle invasive bladder cancer in humans. Front Oncol 9:1493.

Knudson A.G. Jr. (1971) Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820–823.

Konopka J.B., Witte O.N. (1985) Activation of the abl oncogene in murine and human leukemias. Biochim Biophys Acta 823:1–17.

Koretzky G.A. (2007) The legacy of the Philadelphia chromosome. J Clin Invest 117:2030–2032.

Lange M., Begolli R., Giakountis A. (2021) Non-coding variants in cancer: Mechanistic insights and clinical potential for personalized medicine. Noncoding RNA. 7(3): 47.

Lashnits E., Neupane P., Bradley J.M. et al. (2020) Molecular prevalence of Bartonella, Babesia, and hemotropic Mycoplasma species in dogs with hemangiosarcoma from across the United States. PLoS One 15:e0227234.

LeBlanc A.K., Mazcko C.N. (2020) Improving human cancer therapy through the evaluation of pet dogs.

Levitt N.C., Hickson I.D. (2002) Caretaker tumour suppressor genes that defend genome integrity. Trends Mol Med 8:179–186.

Li J., Yuan J. (2008) Caspases in apoptosis and beyond. Oncogene 27:6194–6206.

Linenberger M.L., Abkowitz J.L. (1995) Haematological disorders associated with feline retrovirus infections. Baillieres Clin Haematol 8:73–112.

Liu Y., West S.C. (2002) Distinct functions of BRCA1 and BRCA2 in double-strand break repair. Breast Cancer Res 4:9–13.

Loeb L.A. (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075–3079.

Martin D., Gutkind J.S. (2008) Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene 27:S31–S42.

McDonough S.K., Larsen S., Brodey R.S. et al. (1971) A transmissible feline fibrosarcoma of viral origin. Cancer Res 31:953–956.

Moynahan M.E., Chiu J.W., Koller B.H. et al. (1999) Brca1 controls homology-directed DNA repair. Mol Cell 4:511–518.

Nakayama K., Nakayama K. (1998) Cip/Kip cyclin-dependent kinase inhibitors: Brakes of the cell cycle engine during development. Bioessays 20:1020–1029.

Nelson N. (1965) Formal discussion: Chemical and physical carcinogens. Cancer Res 25:1314–1316.

Nowell P.C. (1976) The clonal evolution of tumor cell populations. Science 194:23–28.

Nowell P.C. (1986) Mechanisms of tumor progression. Cancer Res 46:2203–2207.

Oh J.H., Cho J.Y. (2023) Comparative oncology: Overcoming human cancer through companion animal studies. Exp Mol Med 55:725–734.

Ohshima H., Bartsch H. (1994) Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat Res 305:253–264.

Parrish A.B., Freel C.D., Kornbluth S. (2013) Cellular mechanisms controlling caspase activation and function. Cold Spring Harb Perspect Biol 5.

Payne S.R., Kemp C.J. (2005) Tumor suppressor genetics. Carcinogenesis 26:2031–2045.

Pelucchi C., Gallus S., Garavello W. et al. (2006) Cancer risk associated with alcohol and tobacco use: Focus on upper aero-digestive tract and liver. Alcohol Res Health 29:193–198.

Prager B.C., Xie Q., Bao S. et al. (2019) Cancer stem cells: The architects of the tumor ecosystem. Cell Stem Cell 24:41–53.

Pytel P., Lukas R.V. (2009) Update on diagnostic practice: Tumors of the nervous system. Arch Pathol Lab Med 133:1062–1077.

Rabes H.M. (1986) DNA adducts and cell cycle. J Cancer Res Clin Oncol 112:189–195.

Ranen E., Lavy E., Aizenberg I. et al. (2004) Spirocercosis-associated esophageal sarcomas in dogs. A retrospective study of 17 cases (1997–2003). Vet Parasitol 119:209–221.

Redmond D.E. Jr. (1970) Tobacco and cancer: The first clinical report, 1761. N Engl J Med 282:18–23.

Ribelin W.E., Bailey W.S. (1958) Esophageal sarcomas associated with Spirocerca lupi infection in the dog. Cancer 11:1242–1246.

Robert-Guroff M., Markham P.D., Popovic M. et al. (1985) Isolation, characterization, and biological effects of the first human retroviruses: The human T-lymphotropic retrovirus family. Curr Top Microbiol Immunol 115:7–31.

Ross J.S., Fletcher J.A. (1999) HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol 112:S53–S67.

Rundhaug J.E., Fischer S.M. (2010) Molecular mechanisms of mouse skin tumor promotion. Cancers (Basel) 2:436–482.

Ryan D.P., Hong T.S., Bardeesy N. (2014) Pancreatic adenocarcinoma. N Engl J Med 371:2140–2141.

Sager R. (1992) Tumor suppressor genes in the cell cycle. Curr Opin Cell Biol 4:155–160.

Satyanarayana A., Kaldis P. (2009) Mammalian cell-cycle regulation: Several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 28:2925–2939.

Schafer K.A. (1998) The cell cycle: A review. Vet Pathol 35:461–478.

Scheffner M., Huibregtse J.M., Vierstra R.D. et al. (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495–505.

Schneider D.F., Chen H. (2013) New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin 63:374–394.

Sinha R.P., Hader D.P. (2002) UV-induced DNA damage and repair: A review. Photochem Photobiol Sci 1:225–236.

Slaga T.J. (1983) Overview of tumor promotion in animals. Environ Health Perspect 50:3–14.

Solnica-Krezel L., Sepich D.S. (2012) Gastrulation: Making and shaping germ layers. Annu Rev Cell Dev Biol 28:687–717.

Spadari S., Sutherland B.M., Pedrali-Noy G. et al. (1987) Alteration of DNA tertiary structure by physical and chemical carcinogens: Involvement in DNA repair processes. Toxicol Pathol 15:82–87.

Strahm B., Malkin D. (2006) Hereditary cancer predisposition in children: Genetic basis and clinical implications. Int J Cancer 119:2001–2006.

Szabo C.I., King M.C. (1995) Inherited breast and ovarian cancer. Hum Mol Genet 4:1811–1817.

Takebe H., Nishigori C., Tatsumi K. (1989) Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells. J Invest Dermatol 92:236S–238S.

Tam P.P., Kanai-Azuma M., Kanai Y. (2003) Early endoderm development in vertebrates: Lineage differentiation and morphogenetic function. Curr Opin Genet Dev 13:393–400.

Thota R., Pauff J.M., Berlin J.D. (2014) Treatment of metastatic pancreatic adenocarcinoma: A review. Oncology (Williston Park) 28:70–74.

Toyokuni S. (2009) Mechanisms of asbestos-induced carcinogenesis. Nagoya J Med Sci 71:1–10.

Uren A.G., Kool J., Berns A. et al. (2005) Retroviral insertional mutagenesis: Past, present and future. Oncogene 24:7656–7672.

Vander Heiden M.G., Cantley L.C., Thompson C.B. (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324:1029–1033.

Vogelstein B., Kinzler K.W. (2004) Cancer genes and the pathways they control. Nat Med 10:789–799.

Wainscoat J.S., Fey M.F. (1990) Assessment of clonality in human tumors: A review. Cancer Res 50:1355–1360.

Wang S., El-Deiry W.S. (2003) TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22:8628–8633.

Ward J.F. (1988) DNA damage produced by ionizing radiation in mammalian cells: Identities, mechanisms of formation, and reparability. Prog Nucleic Acid Res Mol Biol 35:95–125.

Waring P., Mullbacher A. (1999) Cell death induced by the Fas/Fas ligand pathway and its role in pathology. Immunol Cell Biol 77:312–317.

Westbrook C.A. (1988) The ABL oncogene in human leukemias. Blood Rev 2:1–8.

Wood C., Scott E.M. (2019) Feline ocular post-traumatic sarcomas: Current understanding, treatment and monitoring. J Feline Med Surg 21:835–842.

Wright S.C., Zhong J., Larrick J.W. (1994) Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J 8:654–660.

Yamagiwa K., Ichikawa K. (1977) Experimental study of the pathogenesis of carcinoma. CA Cancer J Clin 27:174–181.

Yuan S., Akey C.W. (2013) Apoptosome structure, assembly, and procaspase activation. Structure 21:501–515.

Zimmermann K.C., Bonzon C., Green D.R. (2001) The machinery of programmed cell death. Pharmacol Ther 92:57–70.